TriSalus Life Sciences, Inc. Public Float
TriSalus Life Sciences, Inc. (TLSI) had Public Float of $111.50 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $111.50M.
- 2024-06-28: Entity Public Float $82.41M.
- 2023-06-30: Entity Public Float $11.65M.
- 2022-06-30: Entity Public Float $246.13M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $111.50M 10-K · filed 2026-03-05 |
| 2024-06-28 | $82.41M 10-K/A · filed 2025-05-30 |
| 2023-06-30 | $11.65M 10-K · filed 2024-04-11 |
| 2022-06-30 | $246.13M 10-K · filed 2023-03-22 |
| 2021-06-30 | $242.50M 10-K · filed 2022-03-03 |
| 2021-03-29 | $250.00M 10-K/A · filed 2021-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |